Astrazeneca Pharma India's Stock Performance Soars, Receives 'Hold' Call from MarketsMOJO

Astrazeneca Pharma India, a midcap pharmaceutical company, saw a positive trend in its stock performance on September 6th, 2024. The stock gained 5.76%, closing at Rs 7275. This was 3.78% away from its 52-week high of Rs 7550.

According to MarketsMOJO, a leading stock analysis platform, the stock has been given a 'Hold' call. This indicates that the stock is expected to perform steadily in the near future.

In terms of price performance, Astrazeneca Pharma India outperformed the sector by 5.99% on September 6th. The stock also touched an intraday high of Rs 7275, showing a strong upward movement.

Furthermore, Astrazeneca Pharma India is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This indicates a positive trend in the stock's performance.

In comparison to the overall market, Astrazeneca Pharma India has performed exceptionally well. On September 6th, the stock's 1-day performance was 5.43%, while the Sensex's performance was -0.88%. Similarly, the stock's 1-month performance was 3.93%, while the Sensex's performance was 3.67%.

Overall, Astrazeneca Pharma India has shown a strong and consistent performance in the stock market. With a 'Hold' call from MarketsMOJO and positive price movements, the company is expected to continue its upward trend in the near future.